Showing results (341-350 of 355) with videos related to
Sort By:
Pageof 36
Cell Reports|November 26, 2023
Molecular determinants of cross-reactivity and potency by VH3-33 antibodies against the Plasmodium falciparum circumsporozoite proteinElaine Thai, Rajagopal Murugan, Špela Binter, et al.JCI Insight|October 8, 2024
Identification of RTS,S/AS01 vaccine-induced humoral biomarkers predictive of protection against controlled human malaria infectionRachel L Spreng, Kelly E Seaton, Lin Lin, et al.Retrovirology|January 12, 2013
Postnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variantsGenevieve G Fouda, Tatenda Mahlokozera, Jesus F Salazar-Gonzalez, et al.Science Translational Medicine|July 31, 2024
A comparative immunological assessment of multiple clinical-stage adjuvants for the R21 malaria vaccine in nonhuman primatesPrabhu S Arunachalam, NaYoung Ha, S Moses Dennison, et al.Frontiers in Big Data|July 2, 2021
Comprehensive Data Integration Approach to Assess Immune Responses and Correlates of RTS,S/AS01-Mediated Protection From Malaria Infection in Controlled Human Malaria Infection TrialsWilliam Chad Young, Lindsay N Carpp, Sidhartha Chaudhury, et al.Journal of Virology|January 12, 2018
HIV-1-Specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galactosylceramide Blocking and PhagocytosisSaintedym Wills, Kwan-Ki Hwang, Pinghuang Liu, et al.Database : the Journal of Biological Databases and Curation|February 10, 2023
Coronavirus Immunotherapeutic Consortium DatabaseJarjapu Mahita, Brendan Ha, Anais Gambiez, et al.Nature Medicine|January 3, 2024
A candidate antibody drug for prevention of malariaKatherine L Williams, Steve Guerrero, Yevel Flores-Garcia, et al.Iscience|April 22, 2026
Coordinated immune response distinguishes duration of SARS-CoV-2 viral particle shedding in humansDaniel J Schuster, Shuying S Li, Dieter Mielke, et al.Immunity|December 20, 2014
Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conservedKevin Wiehe, David Easterhoff, Kan Luo, et al.Pageof 36